KZR

$0.00

(

+0.00%

) Quote details
Add to Watchlist Run Backtest
stock

Kezar Life Sciences Inc

NASDAQ | KZR

6.36

USD

+$0.00

(

+0.00%

)

At Close (As of Oct 17, 2025)

$30.54M

Market Cap

-

P/E Ratio

-9.7

EPS

$8.44

52 Week High

$3.53

52 Week Low

HEALTHCARE

Sector

KZR Chart

Recent Chart
Price Action

KZR Technicals

Tags:

KZR Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit -$1M
Total Revenue $0
Cost Of Revenue $1M
Costof Goods And Services Sold $1M
Operating Income -$91M
Selling General And Administrative $23M
Research And Development $66M
Operating Expenses $91M
Investment Income Net -
Net Interest Income $6.9M
Interest Income $8.5M
Interest Expense $1.6M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $1M
Income Before Tax -$84M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$84M
Comprehensive Income Net Of Tax -
Ebit -$82M
Ebitda -$81M
Net Income -$84M

Revenue & Profitability

Earnings Performance

KZR Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $145M
Total Current Assets $137M
Cash And Cash Equivalents At Carrying Value $42M
Cash And Short Term Investments $42M
Inventory -
Current Net Receivables $424K
Total Non Current Assets $7.2M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets -
Intangible Assets Excluding Goodwill -
Goodwill -
Investments -
Long Term Investments -
Short Term Investments $90M
Other Current Assets $4.8M
Other Non Current Assets -
Total Liabilities $28M
Total Current Liabilities $20M
Current Accounts Payable $3.7M
Deferred Revenue -
Current Debt -
Short Term Debt $8.7M
Total Non Current Liabilities $7.4M
Capital Lease Obligations $5.9M
Long Term Debt $5.1M
Current Long Term Debt $5.2M
Long Term Debt Noncurrent -
Short Long Term Debt Total $16M
Other Current Liabilities $7.9M
Other Non Current Liabilities -
Total Shareholder Equity $117M
Treasury Stock -
Retained Earnings -$434M
Common Stock $7K
Common Stock Shares Outstanding $73M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$74M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $1M
Capital Expenditures $29K
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment $80M
Cashflow From Financing $103K
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$84M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit -$1M
Total Revenue $0
Cost Of Revenue $1M
Costof Goods And Services Sold $1M
Operating Income -$91M
Selling General And Administrative $23M
Research And Development $66M
Operating Expenses $91M
Investment Income Net -
Net Interest Income $6.9M
Interest Income $8.5M
Interest Expense $1.6M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $1M
Income Before Tax -$84M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$84M
Comprehensive Income Net Of Tax -
Ebit -$82M
Ebitda -$81M
Net Income -$84M

KZR News

KZR Profile

Kezar Life Sciences Inc Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Kezar Life Sciences, Inc. is a promising clinical-stage biotechnology company headquartered in South San Francisco, California, focused on the development of innovative small molecule therapies targeting immune-mediated diseases and cancer. Leveraging its proprietary drug discovery platform, Kezar is committed to addressing significant unmet medical needs with a strong and diverse pipeline of candidates in various stages of clinical development. This strategic focus not only positions the company as a leader in addressing complex therapeutic challenges but also highlights its potential to substantially improve patient outcomes and reshape treatment paradigms in critical disease areas.

VHAI
-25.00%
$0.00
RANI
+248.26%
$1.64
BYND
+24.15%
$0.64
YYAI
+0.83%
$0.12
YDKG
-40.50%
$0.05
CGBS
-39.47%
$0.03
BITF
-5.11%
$5.01
NVDA
+0.77%
$183.22
INTC
+0.46%
$37.01
RGTI
-3.31%
$46.38
GDXD
+20.23%
$0.72
F
+1.53%
$11.92
PLUG
-2.29%
$3.40
ARTV
+116.96%
$6.01
BURU
+0.85%
$0.34
TSLA
+2.46%
$439.31
DNN
-5.50%
$2.92
BBD
+1.22%
$3.30
IONZ
+7.55%
$3.70
HBAN
+0.84%
$15.50
NIO
-1.17%
$6.75
CAN
-4.19%
$1.60
NVTS
-6.20%
$14.66
HIMS
-15.84%
$49.78
RXRX
-7.86%
$5.86
TLRY
+1.29%
$1.56
AXDX
-61.36%
$0.03
BTG
-6.56%
$5.55
HPE
+2.04%
$22.96
LAES
+4.87%
$6.67
RGTZ
+6.58%
$11.97
ETHD
+2.25%
$4.09
ELBM
+35.36%
$2.22
T
+0.53%
$26.34
BLMZ
-3.85%
$0.18
ACHR
-5.30%
$11.24
AMD
-0.63%
$233.08
CIFR
+0.21%
$18.76
KVUE
+8.36%
$15.29
WTO
-47.99%
$0.07
GNPX
-23.68%
$0.36
LNKS
+30.35%
$0.73
RIG
+0.92%
$3.26
GPUS
-11.96%
$0.32
MARA
-3.42%
$19.57
AAPL
+1.95%
$252.29
BAC
+1.66%
$51.28
JOBY
-2.55%
$15.66
RF
+0.98%
$23.58
SOUN
-8.38%
$19.02
SOFI
-0.22%
$26.54
AMZN
-0.66%
$213.04
QBTS
-5.26%
$38.33
PLTR
+0.01%
$178.15
EPWK
-18.45%
$0.07
ONDS
-7.19%
$7.61
GRAB
-1.22%
$5.64
QUBT
-2.18%
$18.32
ADAP
+2.51%
$0.20
PFE
+1.15%
$24.51
RMBL
+60.50%
$3.21
BMNR
-2.40%
$49.85
SLB
-0.88%
$32.63
ABEV
+0.89%
$2.25
IREN
-1.79%
$60.72
ASST
-7.28%
$0.83
ADD
-25.47%
$0.05
ORCL
-6.92%
$291.31
SNAP
-1.41%
$7.65
CRML
+7.41%
$20.86
DFLI
+2.25%
$1.36
BTBT
-1.08%
$3.65
SRM
+53.27%
$10.30
AAL
-0.25%
$11.86
NEHC
+44.44%
$4.55
NUAI
+44.44%
$4.55
IONQ
-4.04%
$62.94
WULF
+0.50%
$13.93
NAK
-8.48%
$2.04
NOK
+1.05%
$5.74
ATAI
+17.70%
$6.45
RR
-4.05%
$5.44
CLSK
-2.32%
$19.52
GWH
+16.04%
$5.28
SMR
-7.11%
$44.25
APLD
-6.55%
$34.24
CRWV
-3.43%
$136.87
QS
-0.64%
$15.36
GOOGL
+0.73%
$253.30
CUTR
-10.19%
$0.09
PET
-59.91%
$0.04
UUUU
-2.90%
$21.06
VALE
-0.09%
$11.10
WLGS
-5.57%
$0.04
FNB
+3.00%
$15.09
BULL
-6.29%
$11.01
AG
-8.51%
$14.02
VIVK
-29.17%
$0.20
LBRT
+28.30%
$15.32
ETWO
0.00%
$3.30
VHAI
-25.00%
$0.00
RANI
+248.26%
$1.64
BYND
+24.15%
$0.64
YYAI
+0.83%
$0.12
YDKG
-40.50%
$0.05
CGBS
-39.47%
$0.03
BITF
-5.11%
$5.01
NVDA
+0.77%
$183.22
INTC
+0.46%
$37.01
RGTI
-3.31%
$46.38
GDXD
+20.23%
$0.72
F
+1.53%
$11.92
PLUG
-2.29%
$3.40
ARTV
+116.96%
$6.01
BURU
+0.85%
$0.34
TSLA
+2.46%
$439.31
DNN
-5.50%
$2.92
BBD
+1.22%
$3.30
IONZ
+7.55%
$3.70
HBAN
+0.84%
$15.50
NIO
-1.17%
$6.75
CAN
-4.19%
$1.60
NVTS
-6.20%
$14.66
HIMS
-15.84%
$49.78
RXRX
-7.86%
$5.86
TLRY
+1.29%
$1.56
AXDX
-61.36%
$0.03
BTG
-6.56%
$5.55
HPE
+2.04%
$22.96
LAES
+4.87%
$6.67
RGTZ
+6.58%
$11.97
ETHD
+2.25%
$4.09
ELBM
+35.36%
$2.22
T
+0.53%
$26.34
BLMZ
-3.85%
$0.18
ACHR
-5.30%
$11.24
AMD
-0.63%
$233.08
CIFR
+0.21%
$18.76
KVUE
+8.36%
$15.29
WTO
-47.99%
$0.07
GNPX
-23.68%
$0.36
LNKS
+30.35%
$0.73
RIG
+0.92%
$3.26
GPUS
-11.96%
$0.32
MARA
-3.42%
$19.57
AAPL
+1.95%
$252.29
BAC
+1.66%
$51.28
JOBY
-2.55%
$15.66
RF
+0.98%
$23.58
SOUN
-8.38%
$19.02
SOFI
-0.22%
$26.54
AMZN
-0.66%
$213.04
QBTS
-5.26%
$38.33
PLTR
+0.01%
$178.15
EPWK
-18.45%
$0.07
ONDS
-7.19%
$7.61
GRAB
-1.22%
$5.64
QUBT
-2.18%
$18.32
ADAP
+2.51%
$0.20
PFE
+1.15%
$24.51
RMBL
+60.50%
$3.21
BMNR
-2.40%
$49.85
SLB
-0.88%
$32.63
ABEV
+0.89%
$2.25
IREN
-1.79%
$60.72
ASST
-7.28%
$0.83
ADD
-25.47%
$0.05
ORCL
-6.92%
$291.31
SNAP
-1.41%
$7.65
CRML
+7.41%
$20.86
DFLI
+2.25%
$1.36
BTBT
-1.08%
$3.65
SRM
+53.27%
$10.30
AAL
-0.25%
$11.86
NEHC
+44.44%
$4.55
NUAI
+44.44%
$4.55
IONQ
-4.04%
$62.94
WULF
+0.50%
$13.93
NAK
-8.48%
$2.04
NOK
+1.05%
$5.74
ATAI
+17.70%
$6.45
RR
-4.05%
$5.44
CLSK
-2.32%
$19.52
GWH
+16.04%
$5.28
SMR
-7.11%
$44.25
APLD
-6.55%
$34.24
CRWV
-3.43%
$136.87
QS
-0.64%
$15.36
GOOGL
+0.73%
$253.30
CUTR
-10.19%
$0.09
PET
-59.91%
$0.04
UUUU
-2.90%
$21.06
VALE
-0.09%
$11.10
WLGS
-5.57%
$0.04
FNB
+3.00%
$15.09
BULL
-6.29%
$11.01
AG
-8.51%
$14.02
VIVK
-29.17%
$0.20
LBRT
+28.30%
$15.32
ETWO
0.00%
$3.30
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.